Penumbra, Inc. today announced that its management team is scheduled to present at the BMO Prescriptions for Success Healthcare Conference in New York, NY on Wednesday, December 12, 2018.
ALAMEDA, Calif., Nov. 29, 2018 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the BMO Prescriptions for Success Healthcare Conference in New York, NY on Wednesday, December 12, 2018.
| Event: | BMO Prescriptions for Success Healthcare Conference |
| Date: | Wednesday, December 12, 2018 |
| Time: | 10:40am ET / 7:40am PT |
A webcast of the presentation will be available by visiting the investors section of the company’s website at www.penumbrainc.com. The webcast will be available on the company’s website for two weeks following the event.
About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets medical devices and has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs. Penumbra sells its products to hospitals primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra P logo is a trademark of Penumbra, Inc. For more information, visit www.penumbrainc.com.
Investor Relations
Penumbra, Inc.
510-995-2461
Source: Penumbra, Inc.
View original content to download multimedia:http://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-bmo-prescriptions-for-success-healthcare-conference-300757592.html
SOURCE Penumbra, Inc.
Company Codes: NYSE:PEN
